FDA.reportPublic FDA data

Gomekli 1 MG Tablet for Oral Suspension

RxCUI
2705635
RxNorm name
Gomekli 1 MG Tablet for Oral Suspension
Display name
Gomekli 1 MG Tablet for Oral Suspension
Full name
Gomekli 1 MG Tablet for Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c41bf90-5fa7-4935-a95c-e047ea6bbf8eGOMEKLI 1 MG Tablet for Oral Suspension [PSN] · mirdametinib 1 MG Tablet for Oral Suspension [Gomekli] [SBD] · Gomekli 1 MG Tablet for Oral Suspension [SY]36These highlights do not include all the information needed to use GOMEKLI safely and effectively. See full prescribing information for GOMEKLI. GOMEKLI TM (mirdametinib) capsules, for oral use GOMEKLI TM (mirdametinib) tablets for oral suspension Initial U.S. Approval: 202520260511